Government Aided Pharmacy College Permanently Affiliated To University Of Mumbai, Approved By AICTE DTE And PCI, Accreditated by National Board of Accreditation for B. Pharm program (2008-2013)

Only Pharmacy College in INDIA awarded Best Industry Linked Institute in Pharmacy Mentor category by AICTE-CII

MISSION

To educate and train students in the knowledge and practice of pharmaceutical sciences and to contribute to improvement of health of the society, through education and research programs.

VISION

To be a leader in Pharmacy Education, Pharmacy Training, and Research in Pharmaceutical Sciences.

Adjunct Faculty

Name of the Faculty: Dr. (Mrs.) M. S. Nagarsenker

Designation: Emeritus Professor

Email: mangal.nagarsenker@gmail.com

Teaching Fields : Pharmaceutics, Novel drug delivery systems, dispensing pharmacy





Educational Qualifications:

Sr no. Degree University Year of Passing
1) PhD (Tech.) Mumbai University 1989
2) M. Pharm Mumbai University 1981
3) B. Pharm Mumbai University 1978

Awards and Fellowships:(ALL)

Sr no. Award/Fellowship Year of Receipt
1) Prof M. L. Khorana best research paper award for paper: Formulation and Evaluation of Long Circulating Liposomal Amphotericin B: A Scinti-kinetic Study using Tc in BALB/C Mice, Indian journal of pharmaceutical sciences 2011;73(1):57-64 2013
2) Association of Pharmaceutical Teachers of India (APTI) Dr. (Mrs.) Manjushree Pal Best Researcher National Award 2013
3) Amrut Mody Research Fund, Distinguished Researcher National Award 2012
4) Prof. (Mrs.) M. R. Baichwal Visiting fellow in Pharm Sci. and Technology for UICT 2005-2006

Recent Publications: (Best Five in last five years)

Sr no. Paper Title(Best Five in last five years) Jounal Details
1) Role of Nanomedicine in Hepatic Targeting- Deciphering Strategies with Molecular Insights and Preclinical Prospects Drug Delivery Letters,2017
2) Pulmonary delivery of synergistic combination of fluoroquinolone antibiotic complemented with proteolytic enzyme: A novel antimicrobial and antibiofilm strategy Nanomedicine: Nanotechnology, Biology and Medicine,2017
3) Catanionic systems in nanotherapeutics–Biophysical aspects and novel trends in drug delivery applications Journal of Controlled Release,2017
4) Surface-Modified Liposomal Formulation of Amphotericin B: In vitro Evaluation of Potential against Visceral Leishmaniasis AAPS PharmSciTech,2017.
5) In Vitro and Ex Vivo Evaluations of Lipid Anti-Cancer Nanoformulations: Insights and Assessment of Bioavailability Enhancement AAPS PharmSciTech,2016

Recent Patents:(ALL)

Sr no. Patent Title Patent Number
1) A process for preparing oral composition of ondansetron 206316
2) Gastroretentive systems and novel pharmaceutical compositions thereof 234801
3) Novel compositions for improved delivery of drugs with poor aqueous solubility 269000
4) Pharmaceutical Composition Comprising Solid Dispersion of BCS Class II Drugs with Gelucires. 1874/MUM/2014
5) “Apparatus for the determination of dissolution and permeation of drugs” (201721019541)

Awards and Honours

Sr no. Presentation Title(Best Five in last five years) Conference Details
1) Stearylated Arabinogalactan: Mitigating Challenges in Hepatic Disorders Through a Targeted Approach AAPS Annual Meeting and Exposition held in San Diego, CA, U.S.A 2017
2) Novel Estradiol Loaded Cationic Polymeric Nanoparticles for Bone Specific Delivery AAPS Annual Meeting and Exposition held in San Diego, CA, U.S.A 2017
3) Novel osteotropic liposomes: Promising nanosystems in osteoporosis therapy 9th Annual conference on Clinical Pharmacology in Maternal and Child Care organized by the South Asian Chapter of American College of Clinical Pharmacology, 2016
4) Phospholipid Vesicular Systems for Enhanced Nelfinavir Mesylate Bioavailability 9th Annual conference on Clinical Pharmacology in Maternal and Child Care organized by the South Asian Chapter of American College of Clinical Pharmacology, 2016
5) Nelfinavir Mesylate nanoconstructs for improved oral delivery: In vitro and In vivo proof of concept 9th Annual conference on Clinical Pharmacology in Maternal and Child Care organized by the South Asian Chapter of American College of Clinical Pharmacology, 2016

Collaborations: (in current year)

Sr no. Title Industry/institute
1) T. N. Medical College and BYL Nair Charitable Hospital, Mumbai
2) Seth GS Medical College and KEM Hospital, Parel, Mumbai
3) Babha Atomic Research Centre (BARC), Trombay, Mumbai
4) Indian Institute of Chemical Technology (CSIR-IICT), Hyderabad
5) Centre for drug research, University of Helsinki, Finland
6) Department of pharmaceutical technology, F S University of Jena, Germany

Research Area and interest:

»

» Fabrication and characterization of nanocarriers like liposomes, lipid particulates, nanosuspensions, Self nanoemulsifying drug delivery systems in the area of Oncology, pain management, antivirals. » Design and development controlled release and targeted delivery systems. »Investigations on three trademark systems LeciPlex®, Lecithmer® and GeluPearl®. »Evaluation of role of excipients in design of dosage form. »Delivery systems for nucleic acids for improved therapy.


Expertise and instrumental/research facilities you can provide to interested parties:

»

For solid dosage forms which include rapid mixer granulator, fluidized bed coater, GMP model compression machine and dissolution test apparatus.

»

Go to TOP

 

Name of the Faculty: Dr. Rachna Kaul

Designation: Assistant Professor

Email: Rachna.kaul@bcp.edu.in, rachnakaul20@gmail.com

Teaching Fields : Biochemistry, Biotechnology





Educational Qualifications:

Sr no. Degree University Year of Passing
1) Ph. D (Molecular Medicine). Jawaharlal Nehru University, New Delhi 2010
2) M.Sc Biotechnology. Panjab University, Chandigarh 1997
3) B.Sc (Hons) Biochemistry Delhi University 1995

Recent Publications: (Best Five in last five years)

Sr no. Paper Title(Best Five in last five years) Journal Details
1) Human gene encoding hyaluronan binding protein 1 (HABP1/p32/gC1qR): involvement in signaling cascade. Nucleus (2017) doi:10.1007/s13237-017-0207-6.
2) Role of PXR in hepatic cancer: Its influences on liver detoxification capacity and cancer progression. Plos One 2016 Oct 19;11(10) :e0164087. doi: 10.1371/journal.pone.0164087
3) Inhibition of Mucin-Type O-Glycosylation through Metabolic Processing and Incorporation of N-Thioglycolyl-d-galactosamine Peracetate (Ac5GalNTGc) J Am Chem Soc.(2013)Sep 25;135(38):14189-97.doi: 10.1021/ja405189k
4) Overexpression of hyaluronan binding protein 1 (HABP1/p32/gC1qR) in HepG2 cell leads to increased hyaluronan synthesis and cell proliferation by upregulation of cyclin D1 in AKT-dependent pathway J Biol Chem (2012) 28 (23): 19750-64

Awards and Honours

Sr no. Presentation Title(Best Five in last five years) Conference Details
1) Functional Role of Hyaluronan binding protein1 (HABP1) in the regulation of tumor progression by cancerous cells HA 2013, June 2013, Oklahoma, USA
2) Engineering of N-acetyl-D-galactosamine (GalNAc) on cell surface glycans using small molecules modulates glycoforms of CD43 New Frontiers at the Interface of Immunity and Glycobiology, March 2011, Canada
3) Metabolic engineering of carbohydrates on cell surface using small molecules: Modulation of glycoforms of CD43 (leukosialin) Indo-French Symposium on infectious diseases. New Delhi, December 2010
4) Multifaceted regulation of hyaluronan binding protein1 (HABP1/gC1qR/p32) on tumor progression and metastasis 8th International Conference on Hyaluronan (ISHAS), Kyoto, Japan, June 2010

Research Area and interest:

»

Teaching duties include basic and advanced biochemistry, biotechnology. Research interests include cell and molecular biology.

Go to TOP

© Copyright. Bombay College of Pharmacy. All rights reserved. Site created and maintained by: K S Softech